Orpro Therapeutics Alternatives & Competitors

12 companies similar to Orpro Therapeutics

SolAeroMed Inc.

3 Seed $101.04K

Biotechnology Health and Wellness +1

Precigen

Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of ge...

152 Post-IPO Equity $547.90M

Germantown, United States

Biotechnology Health and Wellness +1

Alentis Therapeutics

We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis

73 Series D $364.50M

Allschwil, Switzerland

Biotechnology Health and Wellness

Cargene

Pioneering a new wave of treatments with advanced nucleic acid-based medicines to enhance...

11-50 Seed $19.20M

Biopharma Biotechnology +1

Track all Orpro Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Carisma Therapeutics

Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors

15 Acquired $101.00M

Philadelphia, United Stat...

Biotechnology Health Care +2

Gossamer Bio

Vision * Connection * Innovation

159 Post-IPO Equity $812.00M

San Diego, United States

Biotechnology Health Care +1

Cascadian Therapeutics, Inc.

10 Post-IPO Equity $64.90M

Seattle, United States

Biotechnology Health Care +1

Arvinas

Leading the way in targeted protein degradation therapeutics

305 $585.85M

New Haven, United States

Biotechnology Health Care +2

AVEO Oncology

Committed to delivering medicines that provide a better life for patients with cancer.

197 Post-IPO Equity

Boston, United States

Biotechnology Health Care +2

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

119 Post-IPO Equity $408.00M

South San Francisco, Unit...

Biopharma Biotechnology +3

Senex Biotechnology. Inc.

Preventing Adaptive Drug Resistance and Cancer Metastasis

5 Debt Financing $600.00K

Biotechnology Health and Wellness +1

Cytheris

Advancing therapies to rejuvenate and strengthen the immune systems of patients facing can...

Series D $48.00M

Biopharma Biotechnology +1

About Orpro Therapeutics

OrPro Therapeutics is a San Diego-based preclinical-stage biotechnology company established in 2006. The company, a Johnson & Johnson JLABS alumni, is dedicated to addressing unmet medical needs in acute and chronic respiratory, ophthalmology, and oncology fields. OrPro Therapeutics utilizes a cell-protective biologic...

Business keywords

Biopharmaceutical Company, Preclinical-stage, Respiratory Diseases, Ophthalmology, Oncology, Cell-protective Biologic Drug Platform, Thioredoxin, Inflammation, Mucociliary Functions, Chemotherapy, Radiation, Obstructive Disorders, Retina Diseases, Cancer Therapy, Cystic Fibrosis

Frequently Asked Questions

Companies similar to Orpro Therapeutics include SolAeroMed Inc., Precigen, Alentis Therapeutics, Cargene, Carisma Therapeutics. They work in Biotechnology and Health and Wellness and share Orpro Therapeutics's focus on biopharmaceutical company, oncology and cancer therapy.

Bounce Watch lists 12 companies that share Orpro Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Orpro Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Orpro Therapeutics Profile SolAeroMed Inc. Alternatives Precigen Alternatives Alentis Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Orpro Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.